Science 37 Holdings will effect a 1-for-20 reverse stock split of its outstanding common stock, par value $0.0001 per share, that will become effective on December 8, 2023, at 12:01 a.m., Eastern Time. Science 37’s Common Stock will continue to trade on The Nasdaq Capital Market under the existing symbol “SNCE” and will begin trading on a split-adjusted basis when the market opens on December 8, 2023. The new CUSIP number for the Common Stock following the Reverse Stock Split will be 808644207. The Reverse Stock Split is part of the Company’s plan to regain compliance with the $1.00 minimum bid price requirement for maintaining its listing on Nasdaq. There is no guarantee the Company will meet the minimum bid price requirement. At the Company’s Special Meeting of Stockholders held on November 29, 2023, the Company’s stockholders approved a proposal to authorize a reverse stock split of the Company’s Common Stock, at a ratio within the range of 1-for-5 to 1-for-30. The Company’s board of directors approved a 1-for-20 reverse split ratio, and on December 4, 2023, the Company filed a Certificate of Amendment to its Second Amended and Restated Certificate of Incorporation to effect the Reverse Stock Split effective December 8, 2023.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SNCE:
- Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023
- Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
- Science 37 sees FY23 revenue $58M-$59M, consensus $60M
- Science 37 reports Q3 EPS (12c), consensus (7c)
- Science 37 Reports Third Quarter 2023 Financial Results